Intrinsic Value of S&P & Nasdaq Contact Us

Stereotaxis, Inc. STXS AMEX

American Stock Excha • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+97%

Stereotaxis, Inc. (STXS) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Saint Louis, MO, United States. The current CEO is David Leo Fischel.

STXS has IPO date of 2004-08-12, 139 full-time employees, listed on the American Stock Excha, a market capitalization of $197.42M.

About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.

📍 710 North Tucker Boulevard, Saint Louis, MO 63101 📞 314 678 6100
Company Details
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUnited States
ExchangeAmerican Stock Excha
CurrencyUSD
IPO Date2004-08-12
CEODavid Leo Fischel
Employees139
Trading Info
Current Price$2.03
Market Cap$197.42M
52-Week Range1.54-3.59
Beta1.42
ETFNo
ADRNo
CUSIP85916J409
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message